Clinical trial

Combination Chemotherapy in Treating Patients With Liver Metastases From…

NCT00003834 · Alliance for Clinical Trials in Oncology, Other · Completed

Key facts

NCT number NCT00003834
Title Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer
Official title A Phase II Study of Patients With Unresectable Metastatic Adenocarcinoma of the Colon or Rectum (Per 04/99 Amendment) Old Title: A Phase II Study of Patients With Unresectable Metastatic Adenocarcinoma of the Colon or Rectum Confined to the Liver
Lead sponsor Alliance for Clinical Trials in Oncology, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Phase Phase 2
Study type Interventional
Conditions Colorectal Cancer, Metastatic Cancer
Intervention type Drug
Interventions fluorouracil, leucovorin calcium, oxaliplatin
Enrollment 44
Start date Mar 1, 1999
Primary completion Dec 1, 2005
Completion Dec 1, 2005
First posted Apr 14, 2004
Last update posted Jul 6, 2016
Countries Canada, United States

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies